Our systematic review aims to compare results on circulating S100B levels in five major psychiatric disorders with shared genetic susceptibility: schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, and autistic spectrum disorder. This evidence concerns the gene S100B and attention deficit-hyperactivity disorder.